- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04652713
Breakfast for Young Women (GoDag)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a single-blind randomized Cross-Over trial with 30 women aged 18-30 years, each completing three trials. Participants will consume either dairy-based protein-rich breakfast, isocaloric, fiber matched, fat matched, carbohydrate-rich breakfast or no breakfast in randomized order. Three hours later a standardized ad libitum lunch will be served.
Blood samples will be collected (pre, 10 min, 30 min, 60 min, 120 min, 175 min after breakfast) and VAS rating hunger, satiety and desire to eat will be determined (pre, during breakfast, 10, 30, 60, 90, 120, 180 min, during lunch, after lunch). Twenty-four hour food logs on the day before the test day and on the test day will be collected.
Participants will be characterized by determining height (cm), weight (kg), and body composition by a dual-energy X-ray (DXA) scan before the first test day.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Aarhus University, Department for Public Health, Section for Sport Science
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body mass index > 25
- Age 18-25 years
- Regular exercise < 5 hour per week
Exclusion Criteria:
- illness and use of medication affecting the study outcomes
- allergy towards lactose or gluten
- weightloss/gain >5kg the last 6 months
- dieting
- eating disorder
- pregnancy
- breast feeding
- unable to speak and understand danish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High protein breakfast
Participants will be served a dairy-based protein-rich breakfast meal.
|
High protein yoghurt containing approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) yoghurt with 40 g oats for breakfast. 1 glas of water (150 ml) |
|
Experimental: High carbohydrate breakfast
Participants will be served a carbohydrate-rich breakfast meal
|
Low protein breakfast containing approx. 2 g protein per 100 g. Participants will be asked to consume ~60 g bread, 20 g jam and 250 ml juice for breakfast. 1 glas of water (150 ml) |
|
Experimental: No breakfast
Participants will be served no breakfast
|
1 glas of water (150 ml)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Energy consumption on test days
Time Frame: 0-24 hours
|
Total energy consumption on test days (24 hour food log)
|
0-24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in hunger
Time Frame: 0-3 hours
|
Visual Analog Scale (10 cm) score for feeling of hunger
|
0-3 hours
|
|
Change in satiety
Time Frame: 0-3 hours
|
Visual Analog Scale (10 cm) score for feeling of satiety
|
0-3 hours
|
|
change in desire
Time Frame: 0-3 hours
|
Visual Analog Scale (10 cm) score for feeling of desire to eat
|
0-3 hours
|
|
Change in ghrelin
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Change in leptin
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Change in glucose-dependent insulinotropic polypeptide (GIP)
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Change in Peptide YY (PYY3-36)
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Change in insulin
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Change in glucagon
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Change in glucose
Time Frame: 0-3 hours
|
in blood sample
|
0-3 hours
|
|
Energy consumption the day before a test day (food registration)
Time Frame: 0-24 hours
|
Total energy consumption on the day before the test day
|
0-24 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: Baseline
|
Height in cm
|
Baseline
|
|
Weight
Time Frame: Baseline
|
Weight in kg
|
Baseline
|
|
Body composition fat
Time Frame: Baseline
|
DXA-scanning to determine fat mass
|
Baseline
|
|
Body composition fat free
Time Frame: Baseline
|
DXA-scanning to determine fat free mass
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mette Hansen, Assoc Prof, University of Aarhus
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P11-GoDag
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.